AI outperforms traditional tests for fatty liver diagnosis?
NCT ID NCT07305636
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether artificial intelligence (AI) could more accurately predict liver scarring (fibrosis) in people with metabolic-associated fatty liver disease (MAFLD). Researchers compared AI models using FibroScan and clinical data against standard noninvasive scores like FIB-4 and APRI in 522 Egyptian adults. The goal is to find a better, needle-free way to diagnose fibrosis and reduce the need for liver biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, AI could provide a more accurate, noninvasive way to diagnose liver fibrosis in MAFLD patients, potentially reducing the need for liver biopsies.
What could go wrong
This is a completed study with 522 participants, but AI models may not generalize to other populations or settings. The results need validation before clinical use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAFLD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine
Tanta, Egypt